Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$8.01B
sum of reported positions
Reported positions
489
Changes vs prior quarter
492
132 new · 79 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 155 measured positions in 8 quarters, the typical new or larger position finished −2.9 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.45M | $691M | 8.6% | |
TEVA PHARMACEUTICAL INDS LTD | 12.5M | $412M | 5.1% |
| 1.37M | $397M | 5.0% | |
| 1.1M | $394M | 4.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $5.52B | $8.01B |
| Positions | 436 | 489 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 9% |
| 1.95M |
| $391M |
| 4.9% |
| 1.63M | $389M | 4.9% |
| 484K | $367M | 4.6% |
| 3.91M | $345M | 4.3% |
| 1.94M | $228M | 2.8% |
| 590K | $209M | 2.6% |
| 1.17M | $171M | 2.1% |
| 1.8M | $164M | 2.1% |
| 2.24M | $161M | 2.0% |
| 390K | $155M | 1.9% |
| 2.65M | $151M | 1.9% |
| 519K | $146M | 1.8% |
| 757K | $140M | 1.7% |
| 1.63M | $135M | 1.7% |
| 1.34M | $128M | 1.6% |
| 1.41M | $123M | 1.5% |
| 1.14M | $121M | 1.5% |
| 24M | $120M | 1.5% |
| 360K | $118M | 1.5% |
| 667K | $113M | 1.4% |
| 610K | $99.8M | 1.2% |
Nextdoor Holdings (NXDR)
666K shares in Q1 2026
SATELLOGIC INC
162K shares in Q1 2026
TILRAY BRANDS INC
79K shares in Q1 2026
Nexgen Energy (NXE)
56K shares in Q1 2026
COTERRA ENERGY INC
33K shares in Q1 2026
Bank of America (BAC) · CALL
21K shares in Q1 2026
SELECT SECTOR SPDR TR · CALL
21K shares in Q1 2026
Vontier (VNT)
16K shares in Q1 2026
Wells Fargo (WFC) · CALL
13K shares in Q1 2026
EXPEDIA GROUP INC
12K shares in Q1 2026
Citigroup (C) · CALL
9,500 shares in Q1 2026
Sempra (SRE)
8,414 shares in Q1 2026
Argan, Inc. (AGX)
7,079 shares in Q1 2026
PayPal (PYPL) · CALL
7,000 shares in Q1 2026
ITRON INC
5,509 shares in Q1 2026
TEVA PHARMACEUTICAL INDS LTD · CALL
4,780 shares in Q1 2026
MICROSOFT CORP · CALL
3,600 shares in Q1 2026
CNH Industrial (CNH)
3,488 shares in Q1 2026
Lowe's (LOW)
3,347 shares in Q1 2026
Taiwan Semiconductor Manufacturing (TSM) · CALL
3,000 shares in Q1 2026
Nike (NKE)
2,990 shares in Q1 2026
Nuscale Power (SMR)
2,594 shares in Q1 2026
AES Corporation (AES)
2,417 shares in Q1 2026
NOV Inc. (NOV)
2,030 shares in Q1 2026
Conagra Brands (CAG)
1,931 shares in Q1 2026